Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(2):101; doi:10.1093/jnci/91.2.101
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 2, 101, January 20, 1999
© 1999 Oxford University Press

IN THIS ISSUE

Simian Virus 40 and Human Cancer

Simian virus 40 (SV40), a polyomavirus that originated in rhesus monkeys, was discovered as a contaminant of polio vaccines given to millions of people from 1955 through 1963. This virus has been studied extensively since its discovery and has been shown to induce tumors in rodents and to transform many types of cultured cells, including human cells. However, it is not clear whether SV40 produces tumors in humans. Butel and Lednicky (p. 119) review various aspects of SV40 . . . [Full Text of this Article]

Viral Vector Boosts Immunity to Tumors

Blocking Oncoprotein Activity

Inducing Kaposi's Sarcoma Cell Death

Antisense: Suppressing the Suppressor?


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?